Skip to content
How to use Judgment tools
  1. Click Tools to open PDF, Print, Tag, Note, Favourite, and CiteSignal.
  2. Use Brief & Ask in the toolbar for the AI Brief and case chat.
  3. Jump to sections with the pills below the help bar.

Commissioner of Central Excise, Vs. Gan Pharmaceuticals P. Ltd.

Commissioner of Central Excise, vs Gan Pharmaceuticals P. Ltd.

Type Court Judgment Court Customs Excise and Service Tax Appellate Tribunal CESTAT Mumbai Decided Oct 30, 2001
~1 min read
https://sooperkanoon.com/case/26432

For advocates & juniors · 7-day free trial

Brief this judgment before chambers

Stop skimming 50 pages - get an 18-section AI Brief on this case, ask scoped follow-ups, and find related precedents with Semantic Search. Full trial, no card required.

  • 18-section brief - facts, issues, ratio, relief
  • Ask this case - answers cite the judgment
  • Semantic search - find precedents by meaning
  • Research drawer - sections, cites, related cases

No card required · credentials emailed · Log in if you already have an account

Citation
Court
Customs Excise and Service Tax Appellate Tribunal CESTAT Mumbai
Decided On
Subject
Service Tax

Case Summary

AI-generated summary - not the official court judgment text.

Service Tax

Key legal issue
Service Tax

Parties & Advocates

Appellant / Petitioner

Commissioner of Central Excise,

Respondent

Gan Pharmaceuticals P. Ltd.

Excerpt

1. the above appeal arises out of the order of the commissioner (appeals) extending modvat credit on the strength of subsidiary certificates showing delivery of the inputs covered thereunder the respondents, even though there was no specific endorsement by m/s.warren pharmaceuticals pvt. ltd. in favour of the respondents.2. on hearing both sides and noting that the subsidiary certificate themselves show that the inputs were delivered to the respondents and further noting that there is no dispute regarding duty paid of input (sic) in question i hold that there is no legal infirmity in the impugned order and accordingly uphold the same and reject the appeal.

Full Judgment

1. The above appeal arises out of the order of the Commissioner (Appeals) extending modvat credit on the strength of subsidiary certificates showing delivery of the inputs covered thereunder the respondents, even though there was no specific endorsement by M/s.

Warren Pharmaceuticals Pvt. Ltd. in favour of the respondents.

2. On hearing both sides and noting that the subsidiary certificate themselves show that the inputs were delivered to the respondents and further noting that there is no dispute regarding duty paid of input (SIC) in question I hold that there is no legal infirmity in the impugned order and accordingly uphold the same and reject the appeal.

Continue Your Research


AI Briefs · Semantic Search · Save & annotate judgments

Start your 7-day free trial